News of the WeekGene Therapy

Blood Test Flags Agent in Death of Penn Subject

Science  25 Jan 2002:
Vol. 295, Issue 5555, pp. 604-605
DOI: 10.1126/science.295.5555.604b

You are currently viewing the summary.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Summary

Exactly what killed Jesse Gelsinger, the first volunteer to die in a human gene therapy trial, remains a mystery, but last week researchers in Germany fingered a feature of his immune system as a prime suspect. They also believe that a simple blood test might be able to prevent similar tragedies in future gene therapy trials.

Related Content